Evidence map›Paper›PMID 37605686›Full record

ReviewCureus2023

Superior Vena Cava Syndrome: An Umbrella Review.

Rajendra P Shah, Olayiwola Bolaji, Sanchit Duhan, Anderson C Ariaga, Bijeta Keisham, Timir Paul, Wael Aljaroudi, M Chadi Alraies

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Corticosteroids in lung cancer.Frontiers in drug safety and regulation · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Rajendra P ShahDepartment of Internal Medicine, Vassar Brothers Medical Center, Poughkeepsie, USA.
Olayiwola BolajiDepartment of Internal Medicine, University of Maryland Capital Regional Medical Center, Largo, USA.
Sanchit DuhanDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, USA.
Anderson C AriagaDepartment of Internal Medicine, Vassar Brothers Medical Center, Poughkeepsie, USA.
Bijeta KeishamSinai Center for Thrombosis and Research, Sinai Hospital of Baltimore, Baltimore, USA.
Timir PaulSection of Interventional Cardiology, University of Tennessee at Nashville/Ascension Saint Thomas Hospital, Nashville, USA.
Wael AljaroudiDepartment of Cardiology, Augusta University Medical College of Georgia, Augusta, USA.
M Chadi AlraiesDepartment of Cardiology, Detroit Medical Center, Detroit, USA.
Augusta University Health · USRegional Medical Center · USDetroit Medical Center · USSaint Thomas Health · USSaint Thomas West Hospital · USVassar Brothers Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superior vena cava syndrome (SVCS) is a medical emergency that encompasses an array of signs and symptoms due to obstruction of blood flow through the superior vena cava (SVC). It poses a significant healthcare burden due to its associated morbidity and mortality. Its impact on the healthcare system continues to grow due to the increasing incidence of the condition. This incidence trend has been attributed to the growing use of catheters, pacemakers, and defibrillators, although it is a rare complication of these devices. The most common cause of SVCS remains malignancies accounting for up to 60% of the cases. Understanding the pathophysiology of SVCS requires understanding the anatomy, the SVC drains blood from the right and left brachiocephalic veins, which drain the head and the upper extremities accounting for about one-third of the venous blood to the heart. The most common presenting symptoms of SVCS are swelling of the face and hand, chest pain, respiratory symptoms (dyspnea, stridor, cough, hoarseness, and dysphagia), and neurologic manifestations (headaches, confusion, or visual/auditory disturbances). Symptoms generally worsen in a supine position. Diagnosis typically requires imaging, and SVCS can be graded based on classification schemas depending on the severity of symptoms and the location, understanding, and degree of obstruction. Over the past decades, the management modalities of SVCS have evolved to meet the increasing burden of the condition. Here, we present an umbrella review providing an overall assessment of the available information on SVCS, including the various management options, their indications, and a comparison of the advantages and disadvantages of these modalities.

Indexed as

cerebral venous thrombosis (cvt)endovascular stent therapymediastinitissuperior vena cava (svc)superior vena cava syndrome

Identifiers

PMID37605686
PMCPMC10439982
OpenAlexW4385067837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.